Visa is acquiring BioCatch, a fraud-prevention software company, from private equity firm Permira for $2.4 billion in cash, according to the announcement. The deal expands Visa's capabilities in behavioral biometrics and fraud detection as payment volumes and attack sophistication grow.
Permira had acquired a majority stake in BioCatch in September 2024 at a $1.3 billion valuation, according to Permira's statement at that time. Visa's acquisition from Permira values BioCatch at $2.4 billion in under a year, though the acquirer and seller have not disclosed a completion timeline for the transaction.
BioCatch uses behavioral biometrics, patterns in how users interact with devices, including typing speed, mouse movement, and touch dynamics, to identify fraudulent transactions in real time. The platform integrates into payment flows at banks and payment networks without requiring additional authentication steps from customers. Visa says the technology reduces false positives in fraud detection, a persistent friction point in payment authorization.
Fraud losses in digital payments have accelerated as attack vectors broaden. Global payment fraud reached $32.4 billion in 2024 according to industry tracking, and card-not-present transactions face mounting vulnerability. Behavioral biometrics operate passively, leaving no additional burden on end users compared to traditional two-factor authentication.

Visa operates one of the world's largest payment networks, processing trillions of dollars annually across billions of cards and digital wallets. Acquisitions of fraud-prevention and security vendors have become routine within the payments infrastructure space; Mastercard acquired Brighterion and NuData in the 2010s for similar fraud-detection capabilities. Large payment networks have begun buying point solutions to build proprietary security layers into their authorization infrastructure.
Permira, which manages roughly $70 billion in assets, has used the BioCatch acquisition as a platform for roll-up deals in the fraud and cybersecurity space. Selling less than a year after acquiring the majority stake gives Permira an exit on the investment, though neither party disclosed a markup or loss on the fund's position.
Visa has not stated when it expects to close the acquisition or what regulatory approvals, if any, it will need. The deal's completion will determine when Visa can fully integrate BioCatch's platform into its settlement and authorization infrastructure.